Since 2015, Liberia has been rebuilding the country’s health system, which was devastated by a civil war that ended in 2003 and again by the Ebola epidemic that ended in 2015. But improvements in the remote clinics are a ways off.
These materials were created by the US Centers for Disease Control and Prevention to promote handwashing.
Uganda is considered a "hot zone" for infectious diseases. Uganda is particularly vulnerable to epidemics because of its unique location near the Congo Basin; its close connection with other countries; the risk from natural disasters; and the ever-present threat of evolving pathogens or antimicrobial resistance.
These posters, produced as part of the family planning organization NURHI in Nigeria, serve a dual purpose. They serve as job aids for service providers and as reminder materials for clients.
This 13-episode Nigerian reality radio program incorporates different interactive elements, such as interviews, discussions, vox pop, testimonials and expert opinions to engage audiences on malaria-related topics. The English version is titled Play Your Part while the Hausa version is titled Taka Naka Rawan.
A video used to stimulate discussion in trainings. It depicts the contrast between theory and practice of clinical diagnosis in a semi-urban Nigerian context. It shows the procedure for conducting RDT for malaria and how a provider can effectively use interpersonal communication to manage clients. Accompanied by a discussion guide.
These are counseling and point of care materials developed for health facility providers and Proprietary Patent Medicine Vendors (PPMV) on adherence to Rapid Diagnotic Test (RDT) for malaria results.
The Global Handbook represents a collaborative effort to provide high-quality, up-to-date guidance for health-care professionals working in low- and middle-income countries.
This update summarizes current evidence and the World Health Organization (WHO) revised guidance regarding the use of hormonal contraception (HC) by women at high risk of acquiring HIV.
The update lists the following guidance:
Women at high risk of HIV should not be restricted from using progestogen-only injectables.